Agents and methods for diagnosis and therapy of cancer and cancer risk assessment

The invention relates to agents and methods for the diagnosis and therapy of cancer and further to the identification of cancer associated marker. The following tumor marker were identified: Q14259 Enhancer of rudimentary homolog, 000151 PDZ and LIM Domain Protein 1, P55072 Transitional Endoplasmati...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Hauptverfasser: TORTOLA PEREZ, SILVIA, SEIBERT, VOLKER, LAMER, STEPHANIE, FOGERON, MARIE-LAURE, VAN DER LINDEN, MARK, HEIM, STEFFEN, ILYNIA, TATIANA, BUSCHMANN, THOMAS, MEUER, JOERN, ROTHMANN, KIRSTEN
Format: Patent
Sprache:eng ; fre ; ger
Schlagworte:
Online-Zugang:Volltext bestellen
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page
container_issue
container_start_page
container_title
container_volume
creator TORTOLA PEREZ, SILVIA
SEIBERT, VOLKER
LAMER, STEPHANIE
FOGERON, MARIE-LAURE
VAN DER LINDEN, MARK
HEIM, STEFFEN
ILYNIA, TATIANA
BUSCHMANN, THOMAS
MEUER, JOERN
ROTHMANN, KIRSTEN
description The invention relates to agents and methods for the diagnosis and therapy of cancer and further to the identification of cancer associated marker. The following tumor marker were identified: Q14259 Enhancer of rudimentary homolog, 000151 PDZ and LIM Domain Protein 1, P55072 Transitional Endoplasmatic Reticulum ATPase, P20142 Gastricsin (pepsinogen C or II), P07492 Beta-2-Glycoprotein I Precursor (apolipoprotein H), P47756 F-Actin Capping Protein Beta subunit, P27824 Calnexin Precursor, P32119 Peroxiredoxin 2, P11021 78 kDa Glucose regulated protein precursor, Q9Y4L1 150 kD Oxygen-regulated Protein Precursor and/or 075493 CA11(downregulated in gastric cancer).
format Patent
fullrecord <record><control><sourceid>epo_EVB</sourceid><recordid>TN_cdi_epo_espacenet_EP1394182A1</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>EP1394182A1</sourcerecordid><originalsourceid>FETCH-epo_espacenet_EP1394182A13</originalsourceid><addsrcrecordid>eNrjZAh0TE_NKylWSMxLUchNLcnITylWSMsvUkjJTEzPyy_OhMiUZKQWJRZUKuSnKSQn5iWnFoFFocyizOJshcTi4tTi4lygWTwMrGmJOcWpvFCam0HBzTXE2UM3tSA_PrW4IDE5NS-1JN41wNDY0sTQwsjR0JgIJQA2fDb4</addsrcrecordid><sourcetype>Open Access Repository</sourcetype><iscdi>true</iscdi><recordtype>patent</recordtype></control><display><type>patent</type><title>Agents and methods for diagnosis and therapy of cancer and cancer risk assessment</title><source>esp@cenet</source><creator>TORTOLA PEREZ, SILVIA ; SEIBERT, VOLKER ; LAMER, STEPHANIE ; FOGERON, MARIE-LAURE ; VAN DER LINDEN, MARK ; HEIM, STEFFEN ; ILYNIA, TATIANA ; BUSCHMANN, THOMAS ; MEUER, JOERN ; ROTHMANN, KIRSTEN</creator><creatorcontrib>TORTOLA PEREZ, SILVIA ; SEIBERT, VOLKER ; LAMER, STEPHANIE ; FOGERON, MARIE-LAURE ; VAN DER LINDEN, MARK ; HEIM, STEFFEN ; ILYNIA, TATIANA ; BUSCHMANN, THOMAS ; MEUER, JOERN ; ROTHMANN, KIRSTEN</creatorcontrib><description>The invention relates to agents and methods for the diagnosis and therapy of cancer and further to the identification of cancer associated marker. The following tumor marker were identified: Q14259 Enhancer of rudimentary homolog, 000151 PDZ and LIM Domain Protein 1, P55072 Transitional Endoplasmatic Reticulum ATPase, P20142 Gastricsin (pepsinogen C or II), P07492 Beta-2-Glycoprotein I Precursor (apolipoprotein H), P47756 F-Actin Capping Protein Beta subunit, P27824 Calnexin Precursor, P32119 Peroxiredoxin 2, P11021 78 kDa Glucose regulated protein precursor, Q9Y4L1 150 kD Oxygen-regulated Protein Precursor and/or 075493 CA11(downregulated in gastric cancer).</description><edition>7</edition><language>eng ; fre ; ger</language><subject>INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIRCHEMICAL OR PHYSICAL PROPERTIES ; MEASURING ; PHYSICS ; TESTING</subject><creationdate>2004</creationdate><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktohtml>$$Uhttps://worldwide.espacenet.com/publicationDetails/biblio?FT=D&amp;date=20040303&amp;DB=EPODOC&amp;CC=EP&amp;NR=1394182A1$$EHTML$$P50$$Gepo$$Hfree_for_read</linktohtml><link.rule.ids>230,308,776,881,25542,76289</link.rule.ids><linktorsrc>$$Uhttps://worldwide.espacenet.com/publicationDetails/biblio?FT=D&amp;date=20040303&amp;DB=EPODOC&amp;CC=EP&amp;NR=1394182A1$$EView_record_in_European_Patent_Office$$FView_record_in_$$GEuropean_Patent_Office$$Hfree_for_read</linktorsrc></links><search><creatorcontrib>TORTOLA PEREZ, SILVIA</creatorcontrib><creatorcontrib>SEIBERT, VOLKER</creatorcontrib><creatorcontrib>LAMER, STEPHANIE</creatorcontrib><creatorcontrib>FOGERON, MARIE-LAURE</creatorcontrib><creatorcontrib>VAN DER LINDEN, MARK</creatorcontrib><creatorcontrib>HEIM, STEFFEN</creatorcontrib><creatorcontrib>ILYNIA, TATIANA</creatorcontrib><creatorcontrib>BUSCHMANN, THOMAS</creatorcontrib><creatorcontrib>MEUER, JOERN</creatorcontrib><creatorcontrib>ROTHMANN, KIRSTEN</creatorcontrib><title>Agents and methods for diagnosis and therapy of cancer and cancer risk assessment</title><description>The invention relates to agents and methods for the diagnosis and therapy of cancer and further to the identification of cancer associated marker. The following tumor marker were identified: Q14259 Enhancer of rudimentary homolog, 000151 PDZ and LIM Domain Protein 1, P55072 Transitional Endoplasmatic Reticulum ATPase, P20142 Gastricsin (pepsinogen C or II), P07492 Beta-2-Glycoprotein I Precursor (apolipoprotein H), P47756 F-Actin Capping Protein Beta subunit, P27824 Calnexin Precursor, P32119 Peroxiredoxin 2, P11021 78 kDa Glucose regulated protein precursor, Q9Y4L1 150 kD Oxygen-regulated Protein Precursor and/or 075493 CA11(downregulated in gastric cancer).</description><subject>INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIRCHEMICAL OR PHYSICAL PROPERTIES</subject><subject>MEASURING</subject><subject>PHYSICS</subject><subject>TESTING</subject><fulltext>true</fulltext><rsrctype>patent</rsrctype><creationdate>2004</creationdate><recordtype>patent</recordtype><sourceid>EVB</sourceid><recordid>eNrjZAh0TE_NKylWSMxLUchNLcnITylWSMsvUkjJTEzPyy_OhMiUZKQWJRZUKuSnKSQn5iWnFoFFocyizOJshcTi4tTi4lygWTwMrGmJOcWpvFCam0HBzTXE2UM3tSA_PrW4IDE5NS-1JN41wNDY0sTQwsjR0JgIJQA2fDb4</recordid><startdate>20040303</startdate><enddate>20040303</enddate><creator>TORTOLA PEREZ, SILVIA</creator><creator>SEIBERT, VOLKER</creator><creator>LAMER, STEPHANIE</creator><creator>FOGERON, MARIE-LAURE</creator><creator>VAN DER LINDEN, MARK</creator><creator>HEIM, STEFFEN</creator><creator>ILYNIA, TATIANA</creator><creator>BUSCHMANN, THOMAS</creator><creator>MEUER, JOERN</creator><creator>ROTHMANN, KIRSTEN</creator><scope>EVB</scope></search><sort><creationdate>20040303</creationdate><title>Agents and methods for diagnosis and therapy of cancer and cancer risk assessment</title><author>TORTOLA PEREZ, SILVIA ; SEIBERT, VOLKER ; LAMER, STEPHANIE ; FOGERON, MARIE-LAURE ; VAN DER LINDEN, MARK ; HEIM, STEFFEN ; ILYNIA, TATIANA ; BUSCHMANN, THOMAS ; MEUER, JOERN ; ROTHMANN, KIRSTEN</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-epo_espacenet_EP1394182A13</frbrgroupid><rsrctype>patents</rsrctype><prefilter>patents</prefilter><language>eng ; fre ; ger</language><creationdate>2004</creationdate><topic>INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIRCHEMICAL OR PHYSICAL PROPERTIES</topic><topic>MEASURING</topic><topic>PHYSICS</topic><topic>TESTING</topic><toplevel>online_resources</toplevel><creatorcontrib>TORTOLA PEREZ, SILVIA</creatorcontrib><creatorcontrib>SEIBERT, VOLKER</creatorcontrib><creatorcontrib>LAMER, STEPHANIE</creatorcontrib><creatorcontrib>FOGERON, MARIE-LAURE</creatorcontrib><creatorcontrib>VAN DER LINDEN, MARK</creatorcontrib><creatorcontrib>HEIM, STEFFEN</creatorcontrib><creatorcontrib>ILYNIA, TATIANA</creatorcontrib><creatorcontrib>BUSCHMANN, THOMAS</creatorcontrib><creatorcontrib>MEUER, JOERN</creatorcontrib><creatorcontrib>ROTHMANN, KIRSTEN</creatorcontrib><collection>esp@cenet</collection></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext_linktorsrc</fulltext></delivery><addata><au>TORTOLA PEREZ, SILVIA</au><au>SEIBERT, VOLKER</au><au>LAMER, STEPHANIE</au><au>FOGERON, MARIE-LAURE</au><au>VAN DER LINDEN, MARK</au><au>HEIM, STEFFEN</au><au>ILYNIA, TATIANA</au><au>BUSCHMANN, THOMAS</au><au>MEUER, JOERN</au><au>ROTHMANN, KIRSTEN</au><format>patent</format><genre>patent</genre><ristype>GEN</ristype><title>Agents and methods for diagnosis and therapy of cancer and cancer risk assessment</title><date>2004-03-03</date><risdate>2004</risdate><abstract>The invention relates to agents and methods for the diagnosis and therapy of cancer and further to the identification of cancer associated marker. The following tumor marker were identified: Q14259 Enhancer of rudimentary homolog, 000151 PDZ and LIM Domain Protein 1, P55072 Transitional Endoplasmatic Reticulum ATPase, P20142 Gastricsin (pepsinogen C or II), P07492 Beta-2-Glycoprotein I Precursor (apolipoprotein H), P47756 F-Actin Capping Protein Beta subunit, P27824 Calnexin Precursor, P32119 Peroxiredoxin 2, P11021 78 kDa Glucose regulated protein precursor, Q9Y4L1 150 kD Oxygen-regulated Protein Precursor and/or 075493 CA11(downregulated in gastric cancer).</abstract><edition>7</edition><oa>free_for_read</oa></addata></record>
fulltext fulltext_linktorsrc
identifier
ispartof
issn
language eng ; fre ; ger
recordid cdi_epo_espacenet_EP1394182A1
source esp@cenet
subjects INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIRCHEMICAL OR PHYSICAL PROPERTIES
MEASURING
PHYSICS
TESTING
title Agents and methods for diagnosis and therapy of cancer and cancer risk assessment
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-02-04T18%3A54%3A40IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-epo_EVB&rft_val_fmt=info:ofi/fmt:kev:mtx:patent&rft.genre=patent&rft.au=TORTOLA%20PEREZ,%20SILVIA&rft.date=2004-03-03&rft_id=info:doi/&rft_dat=%3Cepo_EVB%3EEP1394182A1%3C/epo_EVB%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_id=info:pmid/&rfr_iscdi=true